SERPINB5 and ductal breast carcinoma in situ: In human breast tissue, maspin is expressed in both luminal and myoepithelial cells, and it has been suggested that the maspin-expressing myoepithelial cells form a defensive barrier for the progression from ductal carcinoma in situ to more invasive carcinoma [9].